Literature DB >> 12620219

Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members.

Sophie Janssens1, Rudi Beyaert.   

Abstract

Interleukin-1 receptor-associated kinase (IRAK) was first described as a signal transducer for the proinflammatory cytokine interleukin-1 (IL-1) and was later implicated in signal transduction of other members of the Toll-like receptor (TLR)/IL-1 receptor (IL-1R) family. In the meantime, four different IRAK-like molecules have been identified: two active kinases, IRAK-1 and IRAK-4, and two inactive kinases, IRAK-2 and IRAK-M. All IRAKs mediate activation of nuclear factor-kappaB (NF-kappaB) and mitogen-activated protein kinase (MAPK) pathways. Although earlier observations suggested that IRAKs have redundant functions, this hypothesis is now challenged by knockout studies. Furthermore, recent data imply a role for IRAK-1 in tumor necrosis factor receptor (TNFR) superfamily-induced signaling pathways as well. The scope of this review is to highlight the specific role of different IRAKs and to discuss several mechanisms that contribute to their activation and regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620219     DOI: 10.1016/s1097-2765(03)00053-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  162 in total

1.  Innate immune function of the adherens junction protein p120-catenin in endothelial response to endotoxin.

Authors:  Yan-Lei Wang; Yu Sun; Asrar B Malik; Sanyuan Hu; Albert B Reynolds; Richard D Minshall; Guochang Hu
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

2.  Regulated assembly of the Toll signaling complex drives Drosophila dorsoventral patterning.

Authors:  Huaiyu Sun; Par Towb; Daniel N Chiem; Byron A Foster; Steven A Wasserman
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

3.  DNA methylation screening identifies driver epigenetic events of cancer cell survival.

Authors:  Daniel D De Carvalho; Shikhar Sharma; Jueng Soo You; Sheng-Fang Su; Phillippa C Taberlay; Theresa K Kelly; Xiaojing Yang; Gangning Liang; Peter A Jones
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

4.  Requirement of calcium binding, myristoylation, and protein-protein interaction for the Copine BON1 function in Arabidopsis.

Authors:  Yongqing Li; Mingyue Gou; Qi Sun; Jian Hua
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

Review 5.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

6.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

7.  Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine.

Authors:  Amlan Biswas; Jeanette Wilmanski; Huamei Forsman; Tomas Hrncir; Liming Hao; Helena Tlaskalova-Hogenova; Koichi S Kobayashi
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

8.  IRAK-4 mutation (Q293X): rapid detection and characterization of defective post-transcriptional TLR/IL-1R responses in human myeloid and non-myeloid cells.

Authors:  Donald J Davidson; Andrew J Currie; Dawn M E Bowdish; Kelly L Brown; Carrie M Rosenberger; Rebecca C Ma; Johan Bylund; Paul A Campsall; Anne Puel; Capucine Picard; Jean-Laurent Casanova; Stuart E Turvey; Robert E W Hancock; Rebecca S Devon; David P Speert
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 9.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

10.  Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.

Authors:  Teresa Fernandes-Alnemri; Seokwon Kang; Connor Anderson; Junji Sagara; Katherine A Fitzgerald; Emad S Alnemri
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.